Cocrystal Pharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cocrystal Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2013 to Q3 2024.
  • Cocrystal Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $103K, a 63% decline year-over-year.
  • Cocrystal Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $612K.
  • Cocrystal Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $575K.
  • Cocrystal Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$8K, a 122% decline from 2021.
  • Cocrystal Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $36K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $612K $103K -$175K -63% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $787K $105K -$68K -39.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $855K $202K +$280K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $575K $202K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $278K +$284K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $173K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$78K -$75K -2500% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 -$6K -$18K -150% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q1 2022 -$3K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $12K -$27K -69.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $7K +$52K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q4 2020 -$62K -$27K -$107K -134% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $45K $39K +$11K +39.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $34K -$45K -$80K -229% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $114K -$29K -$123K -131% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $237K $80K +$184K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 $53K $28K -$40K -58.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $93K $35K -$200K -85.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $293K $94K -$1K -1.05% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $294K -$104K -$600K -121% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $894K $68K +$218K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $676K $235K +$385K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $291K $95K -$478K -83.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $769K $496K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$150K -$163K -1254% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$150K Apr 1, 2017 Jun 30, 2017 10-Q 2018-11-09
Q1 2017 $573K -$749K -56.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q3 2016 $13K -$3.07M -99.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q1 2016 $4.27M $1.32M +$15.7M Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$11.4M -$1.38M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 $3.08M +$4.41M Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $1.25M -$4.87M -79.6% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q1 2015 -$14.4M -$15.5M -1339% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 -$1.33M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $6.12M +$6.12M +611600% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $1.16M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q2 2013 $1K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.